StreetAlpha.app
Home › Stocks › MEDP

Medpace Holdings, Inc. (MEDP)

Healthcare
$610.54
▼ −3.70%
LAST CLOSE · NOV 20

Medpace provides outsourced clinical trial services to drug, biologic and medical device developers. It last closed at $610.54 on Nov 20, down 3.70% on the day. The next earnings report for MEDP is expected around Mon, Feb 8, 2027, after the close. For the quarter ended Sep 2026, MEDP reported EPS of $4.84 on revenue of $716.0M, with revenue up 8.5% from a year ago. Over its last 8 reports the stock moved an average of 16.0% the session after earnings. Over the last 12 months MEDP insiders bought $0 of stock on the open market and sold $389.2M, according to SEC Form 4 filings.

AI Auto Pilots
Is MEDP in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold MEDP.

Key Stats

Last 12 months
Results
Revenue
$2.8B
+20.4% vs a year ago
Net income
$517.8M
+19.6% vs a year ago
EPS (diluted)
$18.01
+25.9% vs a year ago
Free cash flow
$667.6M
23.5% margin
Valuation
Market cap
$17.1B
28.0M shares
P/E
33.9
Price over 12 month EPS
Price to sales
6.0
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$705.3M
At Sep 30
Shareholder equity
$584.9M
Buybacks
$294.8M
Last 12 months
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $1.1B$1.1BFY2021FY2022: $1.5B$1.5BFY2022FY2023: $1.9B$1.9BFY2023FY2024: $2.1B$2.1BFY2024FY2025: $2.5B$2.5BFY2025

From MEDP's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 22). Last 12 months adds up the four latest quarters.

Next report
Feb 8
Estimated date · After the close
Reported EPS
$4.84
Quarter ended Sep 2026
Year ago EPS
$3.86
+25.4% on a GAAP basis
Revenue
$716.0M
+8.5% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $3.67Dec '24Mar 2025: $3.67Mar '25Jun 2025: $3.10Jun '25Sep 2025: $3.86Sep '25Dec 2025: $4.64Dec '25Mar 2026: $4.28Mar '26Jun 2026: $4.25Jun '26Sep 2026: $4.84Sep '26Latest $4.84
Revenue by quarter
Dec 2024: $536.6MDec '24Mar 2025: $558.6MMar '25Jun 2025: $603.3MJun '25Sep 2025: $659.9MSep '25Dec 2025: $708.5MDec '25Mar 2026: $706.6MMar '26Jun 2026: $707.3MJun '26Sep 2026: $716.0MSep '26Latest $716.0M
How MEDP moved after its last 8 reports
Average move the session after a report ±16.0%
Oct 21, 2026After the close−1.3%
Jul 22, 2026After the close+14.7%
Apr 22, 2026After the close−22.6%
Feb 9, 2026After the close−15.9%
Oct 22, 2025After the close+9.1%
Jul 21, 2025After the close+54.7%
Apr 21, 2025After the close−2.3%
Feb 10, 2025After the close−7.5%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on MEDPStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on MEDP
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on MEDP

Technical Analysis

MEDP · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend, nearing oversold

The stock is 8% below its 20 day and 4% below its 50 day average. It is 13% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 38), near oversold. The nearest support is the 100 day average at $606.45, and the nearest resistance the Pivot at $617.05.

Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityNormal, 3.3%/day
Key levels
$693.9752 week high+13.7%
$656.7520 day average+7.6%
$634.5950 day average+3.9%
$628.69Swing high (Sep 30)+3.0%
$627.36Pivot R1+2.8%
$617.05Pivot+1.1%
$610.54Last close
$606.45100 day average−0.7%
$600.22Pivot S1−1.7%
$590.46Swing low (Oct 8)−3.3%
$533.77200 day average−12.6%
$373.0052 week low−38.9%
Indicators
RSI (14)37.91Weak, oversold below 30Neutral
MACD-0.19Below its signal lineBearish
Stochastic14.2Near the bottom of its rangeOversold
ADX (14)25.3Trending down
Williams %R-94.7Oversold below −80, overbought above −20Oversold
CCI (20)-221.9Oversold below −100, overbought above 100Oversold
Rate of change−6.5%Change over 10 sessionsBearish
ATR (14)$20.03Typical daily range, 3.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Above
What happened before, for MEDP

What happened before

See how MEDP did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow MEDP usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How MEDP has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2016.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for MEDPHow many large options trades hit MEDP, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

MEDP Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲375 buying vs 318 selling
  • ▼Held by funds -5.7 pts
  • ▲Funds holding +60
  • ▲Superinvestors: 5 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding762702+8.5%
In funds' top 1065+20.0%
Held by funds82.7%88.3%−5.7 pts
New / increased128 / 24767 / 205+37.9%
Reduced / sold out257 / 61310 / 104−23.2%
Put/call ratio6.660.91+632.2%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See MEDP institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

MEDP Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$389.2M31 sales · 9 insiders
2025-12 sold $17.5M2026-03 sold $14.4M2026-05 sold $7.4M2026-07 sold $8.8M2026-08 sold $73.8M2026-09 sold $125.9M2026-10 sold $14.4MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Oct 29Stephen P EwaldGeneral Counsel & Corp. Secy.Sale1,245$690.00$859K
Oct 27Susan E BurwigExec. VP, OperationsSale20,000$677.00$13.5M
Sep 30August J. TroendlePresident & CEOSale48,667$623.03$30.3M
Sep 28August J. TroendlePresident & CEOSale2,564$620.10$1.6M
Sep 24August J. TroendlePresident & CEOSale43,916$624.01$27.4M
Sep 22August J. TroendlePresident & CEOSale70,901$626.62$44.4M
Every insider buy and sale for MEDP over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See MEDP insider trades →

From SEC Form 4 filings by MEDP's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether MEDP is in one of them and how their past MEDP trades turned out.

MEDP in the AI portfolios
Loading…

MEDP News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered MEDP in an article yet. Here's the latest on the wider market.

MEDP in the news

MEDP Congress Trades

All congress trades →
Trades, 12 months
6
Buys
4
67%
Sells
2
33%
People
2
Last filed May 28
Who traded MEDP · since 2020
Latest 5 filings of 22
$1K – $15KTraded May 15, 2026Filed May 28, 2026
$1K – $15KTraded May 15, 2026Filed May 28, 2026
$1K – $15KTraded Feb 26, 2026Filed Mar 6, 2026
$15K – $50KTraded Jan 15, 2026Filed Feb 13, 2026
$1K – $15KTraded Jan 29, 2026Filed Feb 2, 2026
PersonTypeAmountTradedFiledDelay
David TaylorR · OHBuy$1K – $15KMay 15, 2026May 28, 202613 d
David TaylorR · OHBuy$1K – $15KMay 15, 2026May 28, 202613 d
David TaylorR · OHBuy$1K – $15KFeb 26, 2026Mar 6, 20268 d
Gilbert CisnerosD · CASell$15K – $50KJan 15, 2026Feb 13, 202629 d
David TaylorR · OHBuy$1K – $15KJan 29, 2026Feb 2, 20264 d

From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data

About Medpace Holdings

Medpace is a contract research organization that runs clinical trials for drug, biologic and medical device developers. It provides services across the full clinical development process, from early Phase I testing through Phase IV, including study management, patient recruitment, monitoring, regulatory affairs, biometrics, safety reporting, and laboratory testing. Its customers include small, midsize and large biopharmaceutical and pharmaceutical companies. The company is based in Cincinnati, Ohio.

Headquarters
Cincinnati, OH